The US Food and Drug Administration (FDA) has approved the humanized monoclonal antibody romosozumab (Evenity, Amgen) for treatment of osteoporosis in postmenopausal women with a history of osteoporotic fracture or multiple risk factors for fracture, or those who have failed or are intolerant to other osteoporosis therapies.
The US Food and Drug Administration today granted accelerated approval to atezolizumab (Tecentriq, Genentech/Roche) plus the chemotherapy nab-paclitaxel (Abraxane, Celgene) for the first-line treatment of unresectable locally advanced or metastatic, PD-L1-positive triple-negative breast cancer(TNBC).
之前FDA已經發佈過聲明
現在更是針對牙科產品提出警告
The US Food and Drug Administration (FDA) is warning consumers to immediately stop using benzocaine-containing over-the-counter drug products, including those used to treat teething pain, in infants and children under 2 years of age as they can pose a "serious risk."
The cancer immunotherapy strategy known as programmed cell death 1 (PD-1) blockade has demonstrated efficacy in patients with Hodgkin lymphoma (HL), according to researchers here at the American Society of Hematology (ASH) 56th Annual Meeting.
Over the past decade, complementary and alternative medicine (CAM) has grown into a multi-billion-dollar industry in the United States, with the use of CAM interventions becoming increasingly popular among cancer patients.
A new position statement from the American Diabetes Association (ADA) provides the first-ever guidance specific to the management of type 1 diabetes in all age groups, including a new HbA1c target for children.
The US Food and Drug Administration (FDA) has approved the first-ever nasal testosterone replacement therapy (Natesto Nasal Gel, Trimel Pharmaceuticals).
AMSTERDAM — A new analysis from the large international PURE trial should intensify the ongoing debate over the link between sodium and blood pressure.
MILAN, Italy — The European Society of Hypertension (ESH) and the European Society of Cardiology (ESC) published new guidelines today for the management of hypertension, simplifying treatment decisions for physicians with the recommendation that all patients be treated to <140 mm Hg systolic blood pressure[1].
The US Food and Drug Administration (FDA) has approved Oralair (Stallergenes, Inc), the first sublingual immunotherapy in the United States to treat multiple grass pollens.
Question
If a patient in the emergency department can't communicate, is it a HIPAA violation to call a pharmacy to get medical information?
|
Response from Carolyn Buppert, MSN, JD Healthcare attorney, Boulder, Colorado |
之前也有跟各位討論過：
ACEI與ARB併用之討論
來看看另外的觀點
Hello. This is Jeffrey Berns, Editor-in-Chief of Medscape Nephrology.
醫藥類 (14) 電腦知識 (3) 心情點滴 (3) 部落格摘要 (1) 其他知識 (1)
或請google "Mulicia"
